- Direction
- Unknown
- Own history
- —
- Peers
- 30th
- Persistence
- TRANSIENT
· Pharmaceutical Preparations
RESEARCH SNAPSHOTCelularity Inc's latest supported as-filed period reports revenue of $5.4M; gross margin moved 665 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
Separate current dimensions—not a universal score or investment ranking.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value -20.40% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value -5.30% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 13.22% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 56.79% · CORE
Level · gp.fundamentals.operating_margin
Raw value -78.00% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Raw value 37.33% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Gross margin moved 665 bp lower; Operating margin moved 17170 bp lower.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents decreased 32.1%; Operating cash flow decreased 10.9%.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Gross margin moved 3211 bp lower; Operating margin moved 12013 bp lower.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents increased 25.6%; Operating cash flow changed across a sign change.
2 evidence-backed componentsThis cluster groups 2 independently calculated changes: Cash & equivalents decreased 9.8%; Operating cash flow changed across a low base.
2 evidence-backed componentsCurrent assets changed -62.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
CELU · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001493152-26-049203SEC ↗10-QOct 20, 2026Period Jun 30, 20260001493152-26-047787SEC ↗10-K/AOct 20, 2026Period Dec 31, 20250001493152-26-047708SEC ↗8-KSep 29, 2026Period Sep 29, 20260001493152-26-044917SEC ↗10-QSep 29, 2026Period Mar 31, 20260001493152-26-044892SEC ↗8-KSep 28, 2026Period Sep 18, 20260001493152-26-044421SEC ↗4Sep 25, 2026Period Sep 23, 20260001104659-26-111028SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Sep 23, 2026Filed Sep 25, 2026 | Philip & Daniele Barach Family TrustReporting owner | OtherDirect | 2,140,000 | — | — | Form 4 ↗ |
| Sep 23, 2026Filed Sep 25, 2026 | Philip & Daniele Barach Family TrustReporting owner | OtherDirect | 1,457,765 | — | — | Form 4 ↗ |
| Sep 23, 2026Filed Sep 25, 2026 | Philip & Daniele Barach Family TrustReporting owner | OtherDirect | 1,457,765 | — | — | Form 4 ↗ |
| Sep 23, 2026Filed Sep 25, 2026 | Philip & Daniele Barach Family TrustReporting owner | OtherDirect | 192,771 | — | — | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 15.54% · OPTIONAL
Operating income changed +73.3% from the comparable as-filed period.
Operating margin changed -17170 basis points from the comparable as-filed period.
Cash & equivalents changed -32.1% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
Gross margin changed -665 basis points from the comparable as-filed period.
Operating margin changed -12013 basis points from the comparable as-filed period.
Operating margin changed +19857 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-111027| Philip & Daniele Barach Family TrustReporting owner |
| OtherDirect |
| 1,177,000 |
| — |
| — |
| Form 4 ↗ |
| Jun 19, 2026Filed Jun 23, 2026 | Philip & Daniele Barach Family TrustReporting owner | OtherDirect | 839,160 | — | — | Form 4 ↗ |
| Jun 19, 2026Filed Jun 23, 2026 | Philip & Daniele Barach Family TrustReporting owner | OtherDirect | 1,204,819 | — | — | Form 4 ↗ |